Acharya Narendra Dev College, University of Delhi, Govindpuri, Kalkaji, New Delhi, 110 019 India.
Indian J Microbiol. 2008 Dec;48(4):410-31. doi: 10.1007/s12088-008-0052-z. Epub 2009 Jan 8.
Actinomycetes are one of the most efficient groups of secondary metabolite producers and are very important from an industrial point of view. Among its various genera, Streptomyces, Saccharopolyspora, Amycolatopsis, Micromonospora and Actinoplanes are the major producers of commercially important biomolecules. Several species have been isolated and screened from the soil in the past decades. Consequently the chance of isolating a novel actinomycete strain from a terrestrial habitat, which would produce new biologically active metabolites, has reduced. The most relevant reason for discovering novel secondary metabolites is to circumvent the problem of resistant pathogens, which are no longer susceptible to the currently used drugs. Existence of actinomycetes has been reported in the hitherto untapped marine ecosystem. Marine actinomycetes are efficient producers of new secondary metabolites that show a range of biological activities including antibacterial, antifungal, anticancer, insecticidal and enzyme inhibition. Bioactive compounds from marine actinomycetes possess distinct chemical structures that may form the basis for synthesis of new drugs that could be used to combat resistant pathogens.
放线菌是次级代谢产物生产效率最高的一类微生物,从工业角度来看具有非常重要的地位。在其各种属中,链霉菌属、糖多孢菌属、拟无枝酸菌属、小单孢菌属和游动放线菌属是具有商业重要性的生物分子的主要生产者。过去几十年已经从土壤中分离和筛选了多种放线菌。因此,从陆地生境中分离出一种能够产生新的生物活性代谢物的新型放线菌菌株的机会已经减少。发现新型次级代谢产物的最相关原因是为了规避对抗生素产生耐药性的病原体的问题,这些病原体对目前使用的药物不再敏感。迄今尚未开发的海洋生态系统中存在放线菌。海洋放线菌是新型次级代谢产物的有效生产者,具有多种生物活性,包括抗菌、抗真菌、抗癌、杀虫和抑制酶活性。海洋放线菌的生物活性化合物具有独特的化学结构,可能为合成新的药物奠定基础,这些药物可用于对抗耐药性病原体。